101
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Genetic Diversity and Drug Susceptibility Profiles of Multidrug-Resistant Tuberculosis Strains in Southeast China

, , , , & ORCID Icon
Pages 3979-3989 | Published online: 28 Sep 2021

References

  • KamerbeekJ, SchoulsL, KolkA, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35(4):907–914. doi:10.1128/jcm.35.4.907-914.19979157152
  • LiY, CaoX, LiS, et al. Characterization of Mycobacterium tuberculosis isolates from Hebei, China: genotypes and drug susceptibility phenotypes. BMC Infect Dis. 2016;16(1):107. doi:10.1186/s12879-016-1441-226939531
  • LiuQ, YangD, XuW, et al. Molecular typing of Mycobacterium tuberculosis isolates circulating in Jiangsu province, China. BMC Infect Dis. 2011;11(1):288. doi:10.1186/1471-2334-11-28822026819
  • HunterPR. Reproducibility and indices of discriminatory power of microbial typing methods. J Clin Microbiol. 1990;28(9):1903–1905. doi:10.1128/jcm.28.9.1903-1905.19902229371
  • DongH, LiuZ, LvB, et al. Spoligotypes of Mycobacterium tuberculosis from different provinces of China. J Clin Microbiol. 2010;48(11):4102–4106. doi:10.1128/JCM.00549-1020739484
  • WangJ, LiuY, ZhangCL, et al. Genotypes and characteristics of clustering and drug susceptibility of Mycobacterium tuberculosis isolates collected in Heilongjiang province, China. J Clin Microbiol. 2011;49(4):1354–1362. doi:10.1128/JCM.02274-1021325562
  • LiuZ, PangY, ChenS, et al. A first insight into the genetic diversity and drug susceptibility pattern of Mycobacterium tuberculosis complex in Zhejiang, China. Biomed Res Int. 2016;2016:8937539. doi:10.1155/2016/893753927995145
  • LiD, SongY, YangP, LiX, ZhangAM, XiaX. Genetic diversity and drug resistance of Mycobacterium tuberculosis in Yunnan, China. J Clin Lab Anal. 2019;33(5):e22884. doi:10.1002/jcla.2288430896073
  • DouHY, TsengFC, LinCW, et al. Molecular epidemiology and evolutionary genetics of Mycobacterium tuberculosis in Taipei. BMC Infect Dis. 2008;8(1):170. doi:10.1186/1471-2334-8-17019102768
  • PangY, ZhouY, ZhaoB, et al. Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China. PLoS One. 2012;7(3):e32976. doi:10.1371/journal.pone.003297622412962
  • KruunerA, HoffnerSE, SillastuH, et al. Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol. 2001;39(9):3339–3345. doi:10.1128/JCM.39.9.3339-3345.200111526173
  • AnhDD, BorgdorffMW, VanLN, et al. Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg Infect Dis. 2000;6(3):302–305. doi:10.3201/eid0603.00031210827122
  • GlynnJR, Jennifer WhiteleyPJB, KremerK, van SoolingenD. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis. 2002;8(8):843–849. doi:10.3201/eid0805.02000212141971
  • StavrumR, MphahleleM, OvreasK, et al. High diversity of Mycobacterium tuberculosis genotypes in South Africa and preponderance of mixed infections among ST53 isolates. J Clin Microbiol. 2009;47(6):1848–1856. doi:10.1128/JCM.02167-0819386854
  • ChenL, PangY, MaL, et al. First insight into the molecular epidemiology of Mycobacterium Southwestern China. Biomed Res Int. 2017;2017:2505172.28596961
  • JagielskiT, Augustynowicz-KopecE, ZozioT, RastogiN, ZwolskaZ. Spoligotype-based comparative population structure analysis of multidrug-resistant and isoniazid-monoresistant Mycobacterium tuberculosis complex clinical isolates in Poland. J Clin Microbiol. 2010;48(11):3899–3909. doi:10.1128/JCM.00572-1020810763
  • SupplyP, AllixC, LesjeanS, et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol. 2006;44(12):4498–4510. doi:10.1128/JCM.01392-0617005759
  • HuangTS, LeeSS, TuHZ, et al. Correlation between pyrazinamide activity and pncA mutations in Mycobacterium tuberculosis isolates in Taiwan. Antimicrob Agents Chemother. 2003;47(11):3672–3673. doi:10.1128/AAC.47.11.3672-3673.200314576145
  • CuiZ, WangJ, LuJ, HuangX, ZhengR, HuZ. Evaluation of methods for testing the susceptibility of clinical Mycobacterium tuberculosis isolates to pyrazinamide. J Clin Microbiol. 2013;51(5):1374–1380. doi:10.1128/JCM.03197-1223390285